Show simple item record

THE TEN-YEAR EVOLUTIONARY TRAJECTORY OF A HIGHLY RECURRENT PAEDIATRIC HIGH GRADE NEUROEPITHELIAL TUMOUR WITH MN1:BEND2 FUSION

dc.contributor.authorBurford, A
dc.contributor.authorMackay, A
dc.contributor.authorPopov, S
dc.contributor.authorVinci, M
dc.contributor.authorCarvalho, D
dc.contributor.authorClarke, M
dc.contributor.authorIzquierdo, E
dc.contributor.authorAvery, A
dc.contributor.authorJacques, TS
dc.contributor.authorIngram, WJ
dc.contributor.authorMoore, AS
dc.contributor.authorFrawley, K
dc.contributor.authorHassall, TE
dc.contributor.authorRobertson, T
dc.coverage.spatialDenver, CO
dc.date.accessioned2018-01-24T16:00:17Z
dc.date.issued2018-06-01
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000438339000058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9
dc.identifier.citationNEURO-ONCOLOGY, 2018, 20 pp. 40 - 40 (1)
dc.identifier.issn1522-8517
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1027
dc.identifier.eissn1523-5866
dc.format.extent40 - 40 (1)
dc.languageeng
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS INC
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectOncology
dc.subjectClinical Neurology
dc.subjectNeurosciences & Neurology
dc.titleTHE TEN-YEAR EVOLUTIONARY TRAJECTORY OF A HIGHLY RECURRENT PAEDIATRIC HIGH GRADE NEUROEPITHELIAL TUMOUR WITH MN1:BEND2 FUSION
dc.typeJournal Article
dcterms.dateAccepted2017-12-29
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2018-06-01
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfNEURO-ONCOLOGY
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Glioma Team
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Glioma Team
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Glioma Team
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Glioma Team
pubs.publication-statusPublished
pubs.volume20
pubs.embargo.termsNot known
icr.researchteamGlioma Team
dc.contributor.icrauthorMackay, Alan
dc.contributor.icrauthorClarke, Matthew


Files in this item

Thumbnail
Name:
166698_2_merged_1513875761.pdf
Size:
21.44Mb
Format:
PDF
Description:
Accepted version
View/Open
Thumbnail
Name:
166698_2_supp_5606969_p10dpf.pdf
Size:
6.114Mb
Format:
PDF
Description:
Supporting information
View/Open

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0